- Home
- ACIU vs SMHI Comparison
ACIU vs SMHI Comparison
Compare ACIU & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SMHI
- Stock Information
- Founded
- ACIU 2003
- SMHI 1989
- Country
- ACIU Switzerland
- SMHI United States
- Employees
- ACIU N/A
- SMHI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SMHI Marine Transportation
- Sector
- ACIU Health Care
- SMHI Consumer Discretionary
- Exchange
- ACIU Nasdaq
- SMHI Nasdaq
- Market Cap
- ACIU 213.3M
- SMHI 186.4M
- IPO Year
- ACIU 2016
- SMHI N/A
- Fundamental
- Price
- ACIU $2.90
- SMHI $5.65
- Analyst Decision
- ACIU Strong Buy
- SMHI
- Analyst Count
- ACIU 2
- SMHI 0
- Target Price
- ACIU $10.00
- SMHI N/A
- AVG Volume (30 Days)
- ACIU 343.9K
- SMHI 59.9K
- Earning Date
- ACIU 11-04-2025
- SMHI 10-30-2025
- Dividend Yield
- ACIU N/A
- SMHI N/A
- EPS Growth
- ACIU N/A
- SMHI N/A
- EPS
- ACIU N/A
- SMHI N/A
- Revenue
- ACIU $36,362,036.00
- SMHI $255,033,000.00
- Revenue This Year
- ACIU N/A
- SMHI N/A
- Revenue Next Year
- ACIU $1,022.98
- SMHI $9.97
- P/E Ratio
- ACIU N/A
- SMHI N/A
- Revenue Growth
- ACIU 86.71
- SMHI N/A
- 52 Week Low
- ACIU $1.43
- SMHI $3.63
- 52 Week High
- ACIU $3.99
- SMHI $9.11
- Technical
- Relative Strength Index (RSI)
- ACIU 47.76
- SMHI 36.10
- Support Level
- ACIU $2.89
- SMHI $5.61
- Resistance Level
- ACIU $3.21
- SMHI $5.99
- Average True Range (ATR)
- ACIU 0.33
- SMHI 0.26
- MACD
- ACIU -0.08
- SMHI -0.08
- Stochastic Oscillator
- ACIU 3.95
- SMHI 8.80
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.